Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketone Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104098639A details a cost-effective, high-yield route for 17beta-carboxyl-4-androstene-3-ketone, optimizing supply chain reliability for Finasteride intermediates.
Patent CN111646958B reveals a novel organocatalytic route for carfilzomib intermediates, offering high purity and cost-effective manufacturing solutions for global supply chains.
Novel patent CN106188047B details high-yield synthesis of moxifloxacin intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers seeking scalable solutions.
Novel Pd-Cu catalytic synthesis ensures high yield and purity for pharmaceutical intermediates. Reduces costs and enhances supply chain reliability for global buyers.
Patent CN104844554B reveals alkali-free synthesis for high-purity Nebivolol intermediates. Enhances supply chain reliability and reduces purification costs significantly.
Novel Pd-catalyzed C-H halogenation patent CN110563641B offers cost-effective synthesis for Lonafanib intermediates with enhanced supply chain reliability.
Discover a novel, non-Grignard synthesis for 1-cyclopropyl-2-(2-fluorophenyl) ethyl ketone. Enhanced safety, mild conditions, and scalable manufacturing for antithrombotic APIs.
Patent CN103242261A details a high-yield two-step synthesis for alpha-amino aromatic ketones, offering cost reduction and scalable production for UV curing industries.
Patent CN114450261B reveals safer solvent systems for triketone production. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel patent CN105399790B outlines efficient synthesis reducing steps and costs for pharmaceutical intermediates supply chain stability and high purity production capabilities.
Advanced synthesis of 5 alpha-pregnane-3 beta, 17 alpha-dihydroxyl-20-ketone via novel non-hydrogen debromination. Reliable supplier for Ganaxolone quality control intermediates.
Patent CN107445959A reveals microchannel synthesis for high purity antiviral intermediate with cost and safety advantages for global pharmaceutical supply chains seeking reliable partners.
Patent CN107011133B reveals a green nitrite-catalyzed method for oxidizing benzylic C-H bonds to ketones, offering cost reduction in API manufacturing without metal residues.
Patent CN115215775A reveals a novel one-step acylation rearrangement for clethodim intermediates, offering significant cost reduction and simplified manufacturing for agrochemical suppliers.
Novel synthesis method for MEK inhibitor intermediates ensures safety and scalability for global supply chains.
Patent CN102153434A details a cost-effective ruthenium method for aryl ketones, offering significant supply chain advantages over traditional rhodium processes.
Patent CN103554082B details a safer scalable route for 3-(4-amino-1-isoindolone-2-yl) piperidine-2,6-diketone manufacturing reducing toxic waste and operational hazards significantly.
Patent CN113264816A reveals a base-catalyzed route for high-purity spiro cyclopropane derivatives, offering significant cost reduction in API manufacturing and scalable production.
Novel green synthesis method for alpha-bromo-aromatic ketones using Ru(bpy)3Cl2 photocatalyst, offering high selectivity and mild conditions for pharmaceutical intermediates.
Patent CN104513117B details copper-catalyzed asymmetric decarboxylation for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharma manufacturing.